cytochrome P450 family 7 subfamily B member 1
Zuletzt aktualisiert 19. März 2026
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The CYP7B1 gene is a member of the cytochrome P450 gene family. The enzymes produced from cytochrome P450 genes are involved in the formation and breakdown of various molecules and chemicals within cells. The CYP7B1 gene provides instructions for making an enzyme called oxysterol 7-alpha-hydroxylase. This enzyme is produced primarily in the liver and the brain. In the liver, oxysterol 7-alpha-hydroxylase is involved in the pathway that breaks down cholesterol to form bile acids. Bile acids are a component of a digestive fluid called bile that breaks down fats.
Normal function
The CYP7B1 gene is a member of the cytochrome P450 gene family. The enzymes produced from cytochrome P450 genes are involved in the formation and breakdown of various molecules and chemicals within cells. The CYP7B1 gene provides instructions for making an enzyme called oxysterol 7-alpha-hydroxylase. This enzyme is produced primarily in the liver and the brain. In the liver, oxysterol 7-alpha-hydroxylase is involved in the pathway that breaks down cholesterol to form bile acids. Bile acids are a component of a digestive fluid called bile that breaks down fats.
In the brain, oxysterol 7-alpha-hydroxylase is involved in a pathway that converts certain forms of cholesterol into hormones called neurosteroids. Neurosteroids increase the ability of nerve cells (neurons) to send signals (excitability). Oxysterol 7-alpha-hydroxylase helps maintain normal cholesterol levels in the brain and regulates the effects of neurosteroids on the brain.
Conditions referring to this gene or chromosome
Other names
CBAS3
CP7B
cytochrome P450 7B1
oxysterol 7-alpha-hydroxylase
Related patient information and medicines

Patient information leaflet
Kann ich Schwarze Traubenkerze und Vitamin C zusammen einnehmen?
I... Why this happens Black cohosh and vitamin C are processed by the body through different pathways. Vitamin C is a water-soluble vitamin that does not significantly interfere with the liver enzymes (such as the Cytochrome P450 system) that process black cohosh. Additionally, they do not have overlapping effects that would cause a dangerous.

Patient information leaflet
Kann ich Schwarze Traubensilberkerze und Glucosamin zusammen einnehmen?
Why this happens These two substances are processed by the body through different pathways. Glucosamine is an amino sugar used by the body to build cartilage, while black cohosh is a herbal remedy that primarily affects hormonal pathways or neurotransmitters. They do not compete for the same enzymes in the liver (such as the Cytochrome P450.

Patient information leaflet
Kann ich Glucosamin und Johanniskraut zusammen einnehmen?
T... It is generally considered safe to take these two supplements together. Why this happens Glucosamine is primarily used by the body to build cartilage and does not significantly affect the liver enzymes (Cytochrome P450) that St John's wort is known to influence. St John's wort works by altering brain chemicals and speeding up the breakdown of.

Patient information leaflet
Kann ich Promethazin und Vitamin D3 zusammen einnehmen?
It is generally considered sa... Why this happens Promethazine is an antihistamine processed primarily by the liver's cytochrome P450 enzymes, while vitamin D3 is a fat-soluble vitamin that undergoes a different metabolic pathway (hydroxylation in the liver and kidneys). They do not interfere with each other's absorption, metabolism, or effects in.

Patient information leaflet
Polyzystische Nierenerkrankung
There are different types of polycystic kidney disease: Autosomal dominant polycystic ki. This is an hereditary condition caused by a faulty gene which is inherited from one parent. If symptoms and problems develop, they usually start in adulthood. Autosomal recessiv... Can polycystic kidney disease be cured. There is no cure for polycystic kidney.

Patient information leaflet
6-in-1-Impfstoff
Der 6-in-1-Impfstoff is part of routine childhood immunisations and protects Babys against six different serious illnesses. Three doses are given. Further boosters without all six components are given at other times later in childhood and in... It is given in one single injection into the thigh from one single syringe. This leaflet explains when.
Weiterführende Lektüre und Referenzen
- cytochrome P450 family 7 subfamily B member 1; MedlinePlus, National Library of Medicine.
- Arnoldi A, Crimella C, Tenderini E, Martinuzzi A, D'Angelo MG, Musumeci O, Toscano A, Scarlato M, Fantin M, Bresolin N, Bassi MT. Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet. 2012 Feb;81(2):150-7. doi: 10.1111/j.1399-0004.2011.01624.x. Epub 2011 Jan 31.
- Darios F, Mochel F, Stevanin G. Lipids in the Physiopathology of Hereditary Spastic Paraplegias. Front Neurosci. 2020 Feb 28;14:74. doi: 10.3389/fnins.2020.00074. eCollection 2020.
- Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Marechal L, Fontaine B, Guimaraes J, Isidor B, Chazouilleres O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain. 2009 Jun;132(Pt 6):1589-600. doi: 10.1093/brain/awp073. Epub 2009 May 12.
- Hedera P. Uncomplicated (Pure) Hereditary Spastic Paraplegia Overview. 2000 Aug 15 [updated 2025 Jun 5]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1509/
- Theofilopoulos S, Griffiths WJ, Crick PJ, Yang S, Meljon A, Ogundare M, Kitambi SS, Lockhart A, Tuschl K, Clayton PT, Morris AA, Martinez A, Reddy MA, Martinuzzi A, Bassi MT, Honda A, Mizuochi T, Kimura A, Nittono H, De Michele G, Carbone R, Criscuolo C, Yau JL, Seckl JR, Schule R, Schols L, Sailer AW, Kuhle J, Fraidakis MJ, Gustafsson JA, Steffensen KR, Bjorkhem I, Ernfors P, Sjovall J, Arenas E, Wang Y. Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Invest. 2014 Nov;124(11):4829-42. doi: 10.1172/JCI68506. Epub 2014 Oct 1.
- Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, Wilkinson PA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T, Crosby AH. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet. 2008 Feb;82(2):510-5. doi: 10.1016/j.ajhg.2007.10.001. Epub 2008 Jan 18.
- Xing C, Huang X, Wang D, Yu D, Hou S, Cui H, Song L. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 2023 Jun 12;13(1):106. doi: 10.1186/s13578-023-01053-z.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
19. März 2026 | Neueste Version
1 Mar 2026 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

